Pioneering Medicines' Paul Biondi on today’s deal with Pfizer
- blonca9
- Jul 18, 2023
- 1 min read
Paul Biondi provides context on today’s news that Flagship and Pfizer will be partnering on developing ten new programs.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.